The signing of a letter of intent for a business combination with OSR Holdings could potentially increase the value of Bellevue Life Sciences Acquisition's shares. This is because the business combination could lead to increased revenues and profitability for the combined entity. However, the terms of the deal have not been disclosed, so the exact impact on BLAC's share price is uncertain.